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and hypospadias severity subtypes in Europe over a 10-year 
period and to investigate whether maternal age is associ-
ated with hypospadias.
Methods We included all children with hypospadias 
born from 2001 to 2010 who were registered in 23 
EUROCAT registries. Information on the total number 
of births and maternal age distribution for the registry 
population was also provided. We analyzed the total 
prevalence of hypospadias and relative risks by maternal 
age.
Abstract 
Background Hypospadias is a common congenital mal-
formation. The prevalence of hypospadias has a large geo-
graphical variation, and recent studies have reported both 
increasing and decreasing temporal trends. It is unclear 
whether hypospadias prevalence is associated with mater-
nal age.
Aim To analyze the prevalence and trends of total hypo-
spadias, isolated hypospadias, hypospadias with multiple 
congenital anomalies, hypospadias with a known cause, 
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Results From 2001 to 2010, 10,929 hypospadias cases 
were registered in 5,871,855 births, yielding a total preva-
lence of 18.61 per 10,000 births. Prevalence varied consid-
erably between different registries, probably due to differ-
ences in ascertainment of hypospadias cases. No significant 
temporal trends were observed with the exceptions of an 
increasing trend for anterior and posterior hypospadias 
and a decreasing trend for unspecified hypospadias. After 
adjusting for registry effects, maternal age was not signifi-
cantly associated with hypospadias.
Conclusions Total hypospadias prevalence was stable in 
23 EUROCAT registries from 2001 to 2010 and was not 
significantly influenced by maternal age.
Keywords Ascertainment · Congenital anomaly 
registers · Epidemiology · Hypospadias · Maternal age · 
Prevalence
Introduction
Hypospadias is one of the most common congenital mal-
formations. Hypospadias is often classified into anterior 
hypospadias: the urethral opening is slightly displaced but 
still in the glandular or subcoronal region; middle hypospa-
dias: the urethra opens into the ventral surface of the penis; 
and posterior hypospadias: the urethral opening is located 
in the penoscrotal junction, scrotum, or perineum [1]. The 
severity of hypospadias is not only explained by the ure-
thral location, as many other factors (e.g., level of division 
of the corpus spongiosum, size of the glans, and degree of 
ventral penile hypoplasia) play a role [2]. Hypospadias may 
be associated with chordee, cryptorchidism, and other uro-
genital anomalies. Most patients with hypospadias require 
surgical correction, but medical, social, and sexual problems 
may persist after surgery [3].
The etiology of hypospadias is largely unknown. Some 
hypospadias are monogenetic in origin, but the vast major-
ity of cases seem to be multifactorial with many genetic and 
environmental factors playing a role [4, 5]. One study found 
a higher incidence of hypospadias in offspring of vegetarian 
mothers [6]. However, while several environmental exposures 
and maternal factors have been studied, only low birth weight, 
maternal hypertension, pre-eclampsia, and maternal intrauter-
ine diethylstilbestrol exposure have been consistently associ-
ated with hypospadias [5]. The association between hypospa-
dias and increased maternal age and exposure to endocrine 
disrupting chemicals remains controversial [4, 5, 7].
The prevalence of hypospadias shows large geographi-
cal variation, ranging from 2.0 to 43.2 cases per 10,000 
births [8–10]. It is unclear whether hypospadias prevalence 
is rising. Early studies reported increasing prevalence [8, 
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11, 12], while later studies reported increasing [10, 13–
15], stable, or decreasing prevalence [16–18]. The varying 
prevalence and trends might be explained by genetic or 
environmental risk factors that differ between geographi-
cal regions and which increase or decrease locally over 
time. However, another explanation is methodological dif-
ferences between studies, i.e., ascertainment of hypospa-
dias cases may vary, and glandular hypospadias and hypo-
spadias with known etiology might be excluded from some 
studies, explaining the lower prevalence in some regions. 
Moreover, data on the severity of the hypospadias cases 
are often unavailable.
In this study, we analyzed the prevalence and trends of 
total hypospadias, isolated hypospadias, hypospadias with 
multiple congenital anomalies (MCA), hypospadias with 
a known cause, and hypospadias severity subtypes in 23 
EUROCAT registries from 2001 to 2010. We also investi-
gated whether maternal age was associated with hypospadias 
prevalence. Our study is the largest of its kind in Europe.
Patients and methods
Patient population
EUROCAT registries are population-based, registering 
data on congenital anomalies in live births, fetal deaths 
from 20 weeks of gestational age and terminations of 
pregnancy for fetal anomalies [19]. Cases are actively 
ascertained from multiple sources, but ascertainment var-
ies considerably due to differences in the data sources 
that are accessible to individual registries [20]. Of the 31 
EUROCAT full member registries, 23 provided data for 
this study (Table 1; 5,871,855 births covered). The total 
births covered per year varied from 3040 in Mainz to 
100,360 in Hungary.
All participating registries completed a questionnaire 
concerning their inclusion and ascertainment of hypo-
spadias cases from 2001 to 2010. In 1980, EUROCAT 
guidelines specified that cases with glandular hypospadias 
should only be registered if occurring in combination with 
other major structural malformations [21]. The exclusion of 
this minor form of hypospadias was to be applied locally. 
However, Dolk et al. [16] found that some registries were 
not able to apply the exclusion guideline. In order to ensure 
consistency and standardization of coding between regis-
tries, the exclusion was lifted, and from January 1, 2005, 
glandular hypospadias cases were included [22].
For this study, data were extracted from the EUROCAT 
central database in April 2013 for the years 2001–2010. 
Total hypospadias prevalence rates were calculated as the 
total number of hypospadias cases divided by the total 
number of births (male and female) in the population 
covered by the registry. Hypospadias cases were coded 
by International Classification of Diseases (ICD) Brit-
ish Pediatric Association; ICD9, codes 7526.01–7526.04 
(specified subtypes) and 7526.09 (not otherwise specified, 
NOS) and ICD10, codes Q54.0–Q54.3 (specified sub-
types) and Q54.9 (NOS). Registries were asked to specify 
all cases with ‘other’ hypospadias (ICD10 code Q54.8, 
n = 68), which led to a better classification in the majority 
of cases (n = 48). The remaining 20 ‘other’ hypospadias 
cases were excluded from the analyses because of uncon-
firmed diagnosis. Hypospadias was categorized as isolated 
cases, MCA cases and cases with a known cause using 
the EUROCAT MCA algorithm [23]. In isolated cases, no 
other major structural malformation is present. In MCA 
cases, hypospadias is seen in combination with at least 
one unrelated major structural malformation that cannot be 
explained by an underlying syndrome or sequence. In cases 
with a known cause, the hypospadias has a chromosomal, 
genetic, or teratogenic origin. All MCA cases were manu-
ally reviewed by the EUROCAT Coding and Classification 
committee or by a clinical geneticist (JEH Bergman). In 
two hypospadias cases, the etiology could not be classified 
after manual review and those cases were excluded.
For the maternal age analyses, we calculated hypo-
spadias prevalence rates within six maternal age groups 
(Table 2). Hypospadias cases with unknown maternal 
age (1.5 %) were excluded from the maternal age analy-
ses. Wessex (UK), Hungary, and Isle de la Reunion were 
excluded as maternal age was missing for >20 % of hypo-
spadias cases or they could not provide maternal age 
denominators for the population covered by their registry.
Statistical analysis
Change in the annual prevalence rates over time was 
assessed by the χ2 test for trend and heterogeneity. Results 
were classified as follows:
•	 No significant change in prevalence over time: p ≥ 0.05 
for both linear and nonlinear components;
•	 Significant increasing or decreasing trend: p < 0.05 for 
trend and p ≥ 0.01 for nonlinear change, or p < 0.01 for 
both trend and nonlinear change, and the trend is mono-
tonic;
•	 Significant heterogeneous in time: p < 0.05 for nonlin-
ear change and p > 0.05 for trend, or p < 0.01 for non-
linear change and p ≥ 0.01 for trend.
Multilevel Poisson regression analysis was performed 
using generalized estimating equations (GEE) to take into 
account the dependency of cases within registries. In the 
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GEE, the number of cases was corrected for the number of 
births with year of birth as the predictor.
A Poisson regression model using STATA version 12.1 
was used to derive maternal age-specific relative risks (RR) 
relative to the 25- to 29-year age group baseline. A model 
for all cases of hypospadias adjusting for registry was fitted 
to adjust for the possibility that registries with high propor-
tions of mothers in any one age group would bias the RR 
estimates between age groups.
Results
Registration policy
Only four of the 23 participating registries were able to 
adhere to the original EUROCAT guideline to exclude 
isolated glandular hypospadias prior to 2005 (Table 1). 
Fifteen registries had registered all hypospadias sub-
types (including glandular hypospadias) from 2001 to 
2010, and four registries used different criteria for the 
registration of hypospadias (Table 1). None of the reg-
istries reported a change in case ascertainment specific 
to hypospadias over the study period. However, case 
ascertainment in Dublin was affected by data protection 
issues, and Emilia Romagna increased general ascertain-
ment by adding additional information sources since 
2003 and including cases up to 1 year of age (instead 
of 1 week of age) in 2010. Almost all registries believed 
that their ascertainment of glandular hypospadias was 
incomplete, because these cases are not always notified 
to the registry or they are not diagnosed soon after birth 
and therefore missed in registries that only have data 
from the neonatal period. Only Mainz believed that their 
ascertainment of hypospadias cases was complete, since 
every newborn is examined by registry pediatricians. 
Northern Netherlands requires parental consent to reg-
ister cases, which has been constant at 80 % from 2001 
to 2010. Since 2010, the registry also records the diag-
nosis of cases whose parents did not respond to repeated 
letters asking for consent. Specification of hypospadias 
subtype varied considerably between registries, with the 
percentage of unspecified cases varying between 3.8 and 
87.4 %.
Prevalence and trends over time
A total of 10,929 hypospadias cases were registered 
among 5,871,855 births covered by 23 EUROCAT 
registries from 2001 to 2010, yielding a total prevalence 
of 18.61 per 10,000 births (Table 1). Prevalence var-
ied considerably per registry, from 5.10 in South Portu-
gal to 36.83 per 10,000 births in Mainz. Total hypospa-
dias prevalence was stable from 2001 to 2010 (p value 
trend = 0.136), but the data were heterogeneous over 
time (p = 0.013) (Fig. 1a). Multilevel Poisson regression 
analysis confirmed the heterogeneity between registries 
(p < 0.001) but did not show a significant year-of-birth 
effect (Fig. 1a).
Trend analyses for individual registries showed 
increasing trends in nine registries, decreasing trends in 
five registries, heterogeneity over time in four registries, 
and no significant change in prevalence in five registries 
(Table 1). Of the four registries that excluded glandular 
hypospadias following the original EUROCAT coding 
guideline [21], two had a significant increasing trend, 
and two were significantly heterogeneous over time 
(Table 1). In the four EUROCAT registries with the high-
est hypospadias prevalence, no increasing trend was seen 
(Table 1).
The majority of hypospadias cases was isolated 
(n = 9667; 88.5 %), 9.6 % were MCA (n = 1053), and 
only 1.9 % of cases had hypospadias with a chromosomal 
(n = 112), genetic (n = 86), or teratogenic origin (n = 11). 
There was no significant trend for any of these groups 
(Fig. 1b).
Hypospadias subtypes were specified in 45.6 % 
of cases (n = 4980); 31.5 % had anterior hypospadias 
(n = 3443); 10.2 % had middle hypospadias (n = 1109); 
and 3.9 % had posterior hypospadias (n = 428). For 
hypospadias NOS, a significant decreasing trend was 
observed (p < 0.001), whereas anterior and poste-
rior hypospadias showed a significant increasing trend 
(p < 0.001 and p = 0.005, respectively) (Fig. 1c). Mid-
dle hypospadias showed heterogeneous data over time 
(p = 0.001) (Fig. 1c).
Maternal age and hypospadias prevalence
In this study, teenage mothers had a higher prevalence of 
total hypospadias compared to mothers aged 25–29 years 
(unadjusted RR 1.13, 95 % confidence interval (CI) 1.02–
1.26, Table 2). This association remained when analyses 
were repeated excluding chromosomal anomalies. How-
ever, after adjustment for registry effects, the increased 
hypospadias risk in young mothers was no longer signifi-
cant (adjusted RR 1.12, 95 % CI 1.00–1.24, p = 0.051, 
Table 2).
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Discussion
In this large European study, with more than 5.8 million 
births covered by 23 EUROCAT registries, we found a 
total hypospadias prevalence of 18.61 per 10,000 births 
that was stable from 2001 to 2010. Hypospadias preva-
lence and trends are influenced by the registration poli-
cies of the individual registries, as is apparent from the 
large variations in prevalence and trends per registry 
(Table 1). This could explain the stable prevalence over 
time found in this study compared to a previous EURO-
CAT study reporting an increasing trend over the years 
1999–2008 using data from partly overlapping registries 
[14]. Whether glandular hypospadias is registered or not 
will have a large effect on total hypospadias prevalence 
because anterior hypospadias is by far the most common 
[10, 13]. Ascertainment of hypospadias is incomplete in 
some registries, and this has a large effect on the preva-
lence of hypospadias, thus hindering the evaluation of 
trends. Ascertainment depends on the sources of informa-
tion that registries can access (e.g., if only surgical data 
are available, mild cases can be missed), how cases are 
notified to the registry (active versus passive notifica-
tion), jurisdiction (data protection issues), differences in 
diagnostic methods, screening or treatment per country 
(mild cases might not be diagnosed), and variation in the 
follow-up period of cases (when follow-up is short, mild 
hypospadias may not yet have been diagnosed, or a pre-
putial anomaly can be misdiagnosed as hypospadias) [7, 
16, 24, 25]. The low hypospadias prevalence in South 
Portugal (5.10/10,000 births) is largely due to incomplete 
ascertainment, as ascertainment of all congenital anoma-
lies is low in this registry [26]. The lack of an increasing 
trend in hypospadias prevalence over all EUROCAT reg-
istries combined, as well as in the four EUROCAT regis-
tries with the highest prevalence, and therefore probably 
the best ascertainment, is reassuring.
More reliable prevalence rates and trends can be ascer-
tained by systematically performing standardized examina-
tion of complete birth cohorts, as was done in Rotterdam for 
hypospadias [25] and is routinely done by the Mainz registry. 
In Rotterdam, a hypospadias prevalence of 38 per 10,000 live 
births was seen from 1998 to 2000 [25], very similar to the 
total prevalence of 36.83 per 10,000 births found in Mainz 
from 2001 to 2010. The main drawbacks of this approach are 
that the population size is invariably small, only a very lim-
ited region is covered, and it is more expensive to conduct.
Although environmental factors are known to contrib-
ute to the etiology of hypospadias [4, 5], their role in iso-
lated or MCA hypospadias is largely unknown [18]. In this 
study, no trends over time were seen in isolated or MCA 
hypospadias.
Fig. 1  Prevalence of total hypospadias (a), isolated hypospadias, 
hypospadias with multiple congenital anomalies (MCA), hypo-
spadias with known cause (b) and hypospadias subtypes (c) in 23 
EUROCAT registries 2001–2010. a All hypospadias: heterogeneous 
in time (p value trend = 0.136, p value nonlinear change = 0.013) 
Multilevel Poisson regression analysis: no significant effect of birth 
year (p value = 0.136) Error bars show 95 % confidence interval. b 
Isolated hypospadias: heterogeneous in time (p value trend = 0.137, 
p value nonlinear change = 0.002) Hypospadias with MCA: no sig-
nificant change in prevalence over time (p value trend = 0.576, p 
value nonlinear change = 0.930) Hypospadias with a known cause: 
heterogeneous in time (p value trend = 0.054, p value nonlinear 
change = 0.020). c Hypospadias not otherwise specified (NOS): 
significant decreasing trend (p value trend < 0.001, p value non-
linear change < 0.001, trend is monotonic) Anterior hypospadias: 
significant increasing trend (p value trend < 0.001, p value non-
linear change < 0.001, trend is monotonic) Middle hypospadias: 
heterogeneous in time (p value trend = 0.868, p value nonlinear 
change = 0.001) Posterior hypospadias: significant increasing trend 
(p value trend = 0.005, p value nonlinear change = 0.071)
◂
Table 2  Total hypospadias prevalence and relative risk estimates per maternal age category in 20 EUROCAT registries in 2001–2010
CI confidence interval
Data from Isle de la Reunion, Wessex (UK), and Hungary were excluded. In addition, cases with unknown maternal age (n = 117 among 20 reg-
istries) were also excluded from maternal age analyses
* p value = 0.051
Maternal age  
category (years)
Number of  
hypospadias cases
Number of  
births
Total hypospadias  
prevalence per 10,000  
births (95 % CI)
Unadjusted Relative  
Risk (95 % CI)
Relative Risk 
adjusted by registry 
(95 % CI)
<20 385 194,807 19.8 (17.9–21.8) 1.13 (1.02–1.26) 1.12 (1.00–1.24)*
20–24 1333 710,660 18.8 (17.8–19.8) 1.08 (1.00–1.15) 1.06 (0.99–1.13)
25–29 2161 1,239,528 17.4 (16.7–18.2) 1.00 (Reference) 1.00 (Reference)
30–34 2409 1,428,079 16.9 (16.2–17.6) 0.97 (0.91–1.03) 1.00 (0.94–1.06)
35–39 1253 761,353 16.4 (15.6–17.4) 0.94 (0.88–1.01) 0.99 (0.92–1.06)
40+ 269 156,496 17.2 (15.3–19.4) 0.99 (0.87–1.12) 1.04 (0.92–1.18)
Total 7810 4,490,923 17.4 (17.0–17.8)
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Hypospadias cases were also classified according to 
severity: anterior, middle, or posterior hypospadias. Unfor-
tunately, the severity was known in less than half of hypo-
spadias cases, making interpretation of trends difficult. It 
is possible that the increasing trends in anterior and pos-
terior subtypes found in this study could be explained by 
the decreasing trend in hypospadias NOS, as EUROCAT 
efforts to improve and standardize coding led to better 
specification of hypospadias by some registries over time.
Increased maternal age has been found to be associ-
ated with higher risk of hypospadias in some studies [17, 
27, 28], but not in others [15, 29, 30]. In this study, hypo-
spadias prevalence did not differ significantly between the 
maternal age groups after adjustment for registry, but the 
highest hypospadias prevalence was seen in teenage moth-
ers and not in older mothers.
This study shows both the advantages and disadvantages 
of using birth defect registry data to investigate prevalence 
and trends in hypospadias. While the introduction of new 
EUROCAT coding guidelines in 2005 was intended to 
standardize registration, further efforts are needed to imple-
ment guidelines locally. We recommend better specifica-
tion of cases and increased ascertainment where possible. 
Combining data from birth defects registries with smaller 
studies that can guarantee complete case ascertainment and 
classification will provide optimal information about preva-
lence and trends of hypospadias.
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